Neuralab Limited
Records under this name other than patents Neuralab Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,625,560 | Humanized Antibodies That Recognize Beta Amyloid Peptide now held by Wyeth LLC In force · High confidence | In force | High confidence | |
| US 7,871,615 | Humanized Antibodies That Recognize Beta Amyloid Peptide now held by Wyeth LLC Term ended Term ended Jun 19, 2024 · High confidence | Term ended | Term ended Jun 19, 2024 | High confidence |
| US 8,034,339 | Prevention and Treatment of Amyloidogenic Disease conveyed to Elan Pharma International Limited - now held by Janssen Alzheimer Immunotherapy Lapsed on the fee record Ended Oct 11, 2023 · Low confidence | Lapsed on the fee record | Ended Oct 11, 2023 | Low confidence |
| US 9,051,363 | Humanized Antibodies That Recognize Beta Amyloid Peptide now held by Janssen Sciences Ireland Uc Term ended Term ended Jan 1, 2022 · Medium confidence | Term ended | Term ended Jan 1, 2022 | Medium confidence |
| US 7,790,856 | Humanized Antibodies That Recognize Beta Amyloid Peptide now held by Janssen Alzheimer Immunotherapy Term ended Ended no later than Nov 10, 2020 · Low confidence | Term ended | Ended no later than Nov 10, 2020 | Low confidence |
| US 8,034,348 | Prevention and Treatment of Amyloidogenic Disease conveyed to Elan Pharma International Limited - now held by Janssen Alzheimer Immunotherapy Term ended Ended no later than Sep 2, 2020 · Low confidence | Term ended | Ended no later than Sep 2, 2020 | Low confidence |
| US 8,642,044 | Prevention and Treatment of Amyloidogenic Disease conveyed to Elan Pharma International Limited - now held by Janssen Alzheimer Immunotherapy Term ended Term ended Sep 2, 2020 · Medium confidence | Term ended | Term ended Sep 2, 2020 | Medium confidence |
| US 8,227,403 | A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing Same now held by Janssen Sciences Ireland Uc Lapsed on the fee record Ended Jul 24, 2020 · Medium confidence | Lapsed on the fee record | Ended Jul 24, 2020 | Medium confidence |
| US 6,913,745 | Passive Immunization of Alzhemer's Disease now held by Janssen Sciences Ireland Uc Term ended Ended no later than Jun 1, 2020 · Medium confidence | Term ended | Ended no later than Jun 1, 2020 | Medium confidence |
| US 8,124,081 | Prevention and Treatment of Amyloidogenic Diseases conveyed to Elan Pharma International Limited - now held by Neotope Biosciences Limited Lapsed on the fee record Ended Feb 28, 2020 · Low confidence | Lapsed on the fee record | Ended Feb 28, 2020 | Low confidence |